tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

FSTX

F-Star Therapeutics, Inc. (FSTX) Q4 Earnings Cheat Sheet
Pre-EarningsF-Star Therapeutics, Inc. (FSTX) Q4 Earnings Cheat Sheet
1y ago
FSTX
Three new option listings and option delistings on March 21st
PremiumThe Fly
Three new option listings and option delistings on March 21st
1y ago
FSTX
MYOV
F-Star Therapeutics Blasts Up as Merger Deal Goes Through
PremiumMarket News
F-Star Therapeutics Blasts Up as Merger Deal Goes Through
1y ago
FSTX
F-star Therapeutics announces CFIUS clearance for proposed acquisition by invoX
PremiumThe Fly
F-star Therapeutics announces CFIUS clearance for proposed acquisition by invoX
1y ago
FSTX
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
PremiumPress Releases
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
1y ago
FSTX
F-star, InvoX extend end date of merger agreement to March 3
PremiumThe FlyF-star, InvoX extend end date of merger agreement to March 3
1y ago
FSTX
F-Star Therapeutics Up Big on Last-Minute Win
PremiumMarket News
F-Star Therapeutics Up Big on Last-Minute Win
1y ago
FSTX
F-Star Therapeutics Plunges as Sale Falters
PremiumMarket News
F-Star Therapeutics Plunges as Sale Falters
1y ago
FSTX
invoX Pharma and F-star Therapeutics issue Joint Statement
PremiumPress Releases
invoX Pharma and F-star Therapeutics issue Joint Statement
1y ago
FSTX
invoX Pharma, F-star say ‘actively negotiating’ with CFIUS regarding transaction
PremiumThe Fly
invoX Pharma, F-star say ‘actively negotiating’ with CFIUS regarding transaction
1y ago
FSTX
invoX doesn’t expect CFIUS to clear F-star deal, Dealreporter says
PremiumThe Fly
invoX doesn’t expect CFIUS to clear F-star deal, Dealreporter says
1y ago
FSTX
F-star Therapeutics says invoX offer extended to January 17
PremiumThe Fly
F-star Therapeutics says invoX offer extended to January 17
1y ago
FSTX
F-star says invoX extended offer, in further extension talks after CFIUS warning
PremiumThe FlyF-star says invoX extended offer, in further extension talks after CFIUS warning
1y ago
FSTX
F-star Therapeutics presents clinical data on antitumor activity of FS222
PremiumThe Fly
F-star Therapeutics presents clinical data on antitumor activity of FS222
1y ago
FSTX
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress
PremiumPress Releases
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress
1y ago
FSTX
F-star announces publication of Phase 1 dose-escalation trial of FS118
PremiumThe Fly
F-star announces publication of Phase 1 dose-escalation trial of FS118
1y ago
FSTX
F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
PremiumPress Releases
F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
1y ago
FSTX
F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
PremiumPress Releases
F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
2y ago
FSTX
Sino Biopharmaceutical to Acquire F-star Therapeutics; F-Star Shares Up 60%
PremiumMarket News
Sino Biopharmaceutical to Acquire F-star Therapeutics; F-Star Shares Up 60%
2y ago
FSTX
invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs
PremiumPress ReleasesinvoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs
2y ago
FSTX
2 “Strong Buy” Stocks Around $10 With Triple-Digit Upside Potential
PremiumStock Analysis & Ideas
2 “Strong Buy” Stocks Around $10 With Triple-Digit Upside Potential
3y ago
FSTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >